Game-changing ovarian cancer drug which extends survival by three years gets NHS green light
This article was taken from: https://www.telegraph.co.uk/news/2019/07/25/game-changing-ovarian-cancer-drug-extends-survival-three-years/ By Laura Donnelly, health editor A game-changing drug for women with ovarian cancer – dubbed the “silent killer” – has been approved as an early treatment on the NHS. The treatment, called olaparib, has been found to extend survival by three years among women with particular genetic mutations. Scientists welcomed the…